Antibody therapy in pancreatic cancer: mAb-ye we're onto something? (2021)
Attributed to:
The development of bispecific antibodies to promote proapoptotic immunotherapy in pancreatic cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 1876
Parent Publication: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Issue: 1
ISSN: 0304-419X